カテゴリー： QYResearch, 世界

世界の急性呼吸窮迫症候群(ARDS)治療薬市場

◆英語タイトル：Global Acute Respiratory Distress Syndrome Therapeutics Market Professional Survey Report 2019
◆商品コード：DATA909X02949
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2019年11月15日（※2024年版があります。お問い合わせください）
◆ページ数：102
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,500 ⇒換算￥518,000	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD5,250 ⇒換算￥777,000	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD7,000 ⇒換算￥1,036,000	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※本調査レポートは、急性呼吸窮迫症候群(ARDS)治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、メチルプレドニゾロン、ヒドロコルチゾン、注射用子牛肺サーファクタント、その他に、用途別には、入院患者、外来患者にセグメント区分し、急性呼吸窮迫症候群(ARDS)治療薬の世界市場を分析しました。

・エグゼクティブ・サマリー
・急性呼吸窮迫症候群(ARDS)治療薬の世界市場概要
・急性呼吸窮迫症候群(ARDS)治療薬の製造コスト構成分析
・急性呼吸窮迫症候群(ARDS)治療薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・急性呼吸窮迫症候群(ARDS)治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・急性呼吸窮迫症候群(ARDS)治療薬のセグメント分析（種類別）
（メチルプレドニゾロン、ヒドロコルチゾン、注射用子牛肺サーファクタント、その他）
・急性呼吸窮迫症候群(ARDS)治療薬のセグメント分析（用途別）
（入院患者、外来患者）
・急性呼吸窮迫症候群(ARDS)治療薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Therabron Therapeutics, Inc.、Serendex Pharmaceuticals A/S、Silence Therapeutics Plc、Histocell S.L.、Altor BioScience Corporation、Athersys, Inc.、Faron Pharmaceuticals Oy、FirstString Research, Inc.、GlaxoSmithKline Plc、Phylogica Limited、）
・急性呼吸窮迫症候群(ARDS)治療薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...

【レポートの概要】

The global Acute Respiratory Distress Syndrome Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Acute Respiratory Distress Syndrome Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Acute Respiratory Distress Syndrome Therapeutics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Acute Respiratory Distress Syndrome Therapeutics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Acute Respiratory Distress Syndrome Therapeutics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Therabron Therapeutics, Inc.
Serendex Pharmaceuticals A/S
Silence Therapeutics Plc
Histocell S.L.
Altor BioScience Corporation
Athersys, Inc.
Faron Pharmaceuticals Oy
FirstString Research, Inc.
GlaxoSmithKline Plc
Phylogica Limited

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Methylprednisolone
Hydrocortisone
Calf Pulmonary Surfactant for Injection
Others

Segment by Application
In-Patient
Out-Patient

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Acute Respiratory Distress Syndrome Therapeutics
1.1 Definition of Acute Respiratory Distress Syndrome Therapeutics
1.2 Acute Respiratory Distress Syndrome Therapeutics Segment by Type
1.2.1 Global Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Methylprednisolone
1.2.3 Hydrocortisone
1.2.4 Calf Pulmonary Surfactant for Injection
1.2.5 Others
1.3 Acute Respiratory Distress Syndrome Therapeutics Segment by Applications
1.3.1 Global Acute Respiratory Distress Syndrome Therapeutics Consumption Comparison by Applications (2014-2025)
1.3.2 In-Patient
1.3.3 Out-Patient
1.4 Global Acute Respiratory Distress Syndrome Therapeutics Overall Market
1.4.1 Global Acute Respiratory Distress Syndrome Therapeutics Revenue (2014-2025)
1.4.2 Global Acute Respiratory Distress Syndrome Therapeutics Production (2014-2025)
1.4.3 North America Acute Respiratory Distress Syndrome Therapeutics Status and Prospect (2014-2025)
1.4.4 Europe Acute Respiratory Distress Syndrome Therapeutics Status and Prospect (2014-2025)
1.4.5 China Acute Respiratory Distress Syndrome Therapeutics Status and Prospect (2014-2025)
1.4.6 Japan Acute Respiratory Distress Syndrome Therapeutics Status and Prospect (2014-2025)
1.4.7 Southeast Asia Acute Respiratory Distress Syndrome Therapeutics Status and Prospect (2014-2025)
1.4.8 India Acute Respiratory Distress Syndrome Therapeutics Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Acute Respiratory Distress Syndrome Therapeutics
2.3 Manufacturing Process Analysis of Acute Respiratory Distress Syndrome Therapeutics
2.4 Industry Chain Structure of Acute Respiratory Distress Syndrome Therapeutics

3 Development and Manufacturing Plants Analysis of Acute Respiratory Distress Syndrome Therapeutics
3.1 Capacity and Commercial Production Date
3.2 Global Acute Respiratory Distress Syndrome Therapeutics Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Acute Respiratory Distress Syndrome Therapeutics
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Acute Respiratory Distress Syndrome Therapeutics Production and Capacity Analysis
4.2 Acute Respiratory Distress Syndrome Therapeutics Revenue Analysis
4.3 Acute Respiratory Distress Syndrome Therapeutics Price Analysis
4.4 Market Concentration Degree

5 Acute Respiratory Distress Syndrome Therapeutics Regional Market Analysis
5.1 Acute Respiratory Distress Syndrome Therapeutics Production by Regions
5.1.1 Global Acute Respiratory Distress Syndrome Therapeutics Production by Regions
5.1.2 Global Acute Respiratory Distress Syndrome Therapeutics Revenue by Regions
5.2 Acute Respiratory Distress Syndrome Therapeutics Consumption by Regions
5.3 North America Acute Respiratory Distress Syndrome Therapeutics Market Analysis
5.3.1 North America Acute Respiratory Distress Syndrome Therapeutics Production
5.3.2 North America Acute Respiratory Distress Syndrome Therapeutics Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Acute Respiratory Distress Syndrome Therapeutics Import and Export
5.4 Europe Acute Respiratory Distress Syndrome Therapeutics Market Analysis
5.4.1 Europe Acute Respiratory Distress Syndrome Therapeutics Production
5.4.2 Europe Acute Respiratory Distress Syndrome Therapeutics Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Acute Respiratory Distress Syndrome Therapeutics Import and Export
5.5 China Acute Respiratory Distress Syndrome Therapeutics Market Analysis
5.5.1 China Acute Respiratory Distress Syndrome Therapeutics Production
5.5.2 China Acute Respiratory Distress Syndrome Therapeutics Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Acute Respiratory Distress Syndrome Therapeutics Import and Export
5.6 Japan Acute Respiratory Distress Syndrome Therapeutics Market Analysis
5.6.1 Japan Acute Respiratory Distress Syndrome Therapeutics Production
5.6.2 Japan Acute Respiratory Distress Syndrome Therapeutics Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Acute Respiratory Distress Syndrome Therapeutics Import and Export
5.7 Southeast Asia Acute Respiratory Distress Syndrome Therapeutics Market Analysis
5.7.1 Southeast Asia Acute Respiratory Distress Syndrome Therapeutics Production
5.7.2 Southeast Asia Acute Respiratory Distress Syndrome Therapeutics Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Acute Respiratory Distress Syndrome Therapeutics Import and Export
5.8 India Acute Respiratory Distress Syndrome Therapeutics Market Analysis
5.8.1 India Acute Respiratory Distress Syndrome Therapeutics Production
5.8.2 India Acute Respiratory Distress Syndrome Therapeutics Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Acute Respiratory Distress Syndrome Therapeutics Import and Export

6 Acute Respiratory Distress Syndrome Therapeutics Segment Market Analysis (by Type)
6.1 Global Acute Respiratory Distress Syndrome Therapeutics Production by Type
6.2 Global Acute Respiratory Distress Syndrome Therapeutics Revenue by Type
6.3 Acute Respiratory Distress Syndrome Therapeutics Price by Type

7 Acute Respiratory Distress Syndrome Therapeutics Segment Market Analysis (by Application)
7.1 Global Acute Respiratory Distress Syndrome Therapeutics Consumption by Application
7.2 Global Acute Respiratory Distress Syndrome Therapeutics Consumption Market Share by Application (2014-2019)

8 Acute Respiratory Distress Syndrome Therapeutics Major Manufacturers Analysis
8.1 Therabron Therapeutics, Inc.
8.1.1 Therabron Therapeutics, Inc. Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
8.1.2 Therabron Therapeutics, Inc. Product Introduction, Application and Specification
8.1.3 Therabron Therapeutics, Inc. Acute Respiratory Distress Syndrome Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Serendex Pharmaceuticals A/S
8.2.1 Serendex Pharmaceuticals A/S Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
8.2.2 Serendex Pharmaceuticals A/S Product Introduction, Application and Specification
8.2.3 Serendex Pharmaceuticals A/S Acute Respiratory Distress Syndrome Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Silence Therapeutics Plc
8.3.1 Silence Therapeutics Plc Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
8.3.2 Silence Therapeutics Plc Product Introduction, Application and Specification
8.3.3 Silence Therapeutics Plc Acute Respiratory Distress Syndrome Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Histocell S.L.
8.4.1 Histocell S.L. Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
8.4.2 Histocell S.L. Product Introduction, Application and Specification
8.4.3 Histocell S.L. Acute Respiratory Distress Syndrome Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Altor BioScience Corporation
8.5.1 Altor BioScience Corporation Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
8.5.2 Altor BioScience Corporation Product Introduction, Application and Specification
8.5.3 Altor BioScience Corporation Acute Respiratory Distress Syndrome Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Athersys, Inc.
8.6.1 Athersys, Inc. Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
8.6.2 Athersys, Inc. Product Introduction, Application and Specification
8.6.3 Athersys, Inc. Acute Respiratory Distress Syndrome Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Faron Pharmaceuticals Oy
8.7.1 Faron Pharmaceuticals Oy Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
8.7.2 Faron Pharmaceuticals Oy Product Introduction, Application and Specification
8.7.3 Faron Pharmaceuticals Oy Acute Respiratory Distress Syndrome Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 FirstString Research, Inc.
8.8.1 FirstString Research, Inc. Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
8.8.2 FirstString Research, Inc. Product Introduction, Application and Specification
8.8.3 FirstString Research, Inc. Acute Respiratory Distress Syndrome Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 GlaxoSmithKline Plc
8.9.1 GlaxoSmithKline Plc Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
8.9.2 GlaxoSmithKline Plc Product Introduction, Application and Specification
8.9.3 GlaxoSmithKline Plc Acute Respiratory Distress Syndrome Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Phylogica Limited
8.10.1 Phylogica Limited Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
8.10.2 Phylogica Limited Product Introduction, Application and Specification
8.10.3 Phylogica Limited Acute Respiratory Distress Syndrome Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served

9 Development Trend of Analysis of Acute Respiratory Distress Syndrome Therapeutics Market
9.1 Global Acute Respiratory Distress Syndrome Therapeutics Market Trend Analysis
9.1.1 Global Acute Respiratory Distress Syndrome Therapeutics Market Size (Volume and Value) Forecast 2019-2025
9.2 Acute Respiratory Distress Syndrome Therapeutics Regional Market Trend
9.2.1 North America Acute Respiratory Distress Syndrome Therapeutics Forecast 2019-2025
9.2.2 Europe Acute Respiratory Distress Syndrome Therapeutics Forecast 2019-2025
9.2.3 China Acute Respiratory Distress Syndrome Therapeutics Forecast 2019-2025
9.2.4 Japan Acute Respiratory Distress Syndrome Therapeutics Forecast 2019-2025
9.2.5 Southeast Asia Acute Respiratory Distress Syndrome Therapeutics Forecast 2019-2025
9.2.6 India Acute Respiratory Distress Syndrome Therapeutics Forecast 2019-2025
9.3 Acute Respiratory Distress Syndrome Therapeutics Market Trend (Product Type)
9.4 Acute Respiratory Distress Syndrome Therapeutics Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Acute Respiratory Distress Syndrome Therapeutics Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Acute Respiratory Distress Syndrome Therapeutics
Table Global Acute Respiratory Distress Syndrome Therapeutics Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Acute Respiratory Distress Syndrome Therapeutics Production Market Share by Types in 2018
Figure Methylprednisolone Product Picture
Figure Hydrocortisone Product Picture
Figure Calf Pulmonary Surfactant for Injection Product Picture
Figure Others Product Picture
Table Global Acute Respiratory Distress Syndrome Therapeutics Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Acute Respiratory Distress Syndrome Therapeutics Consumption Market Share by Applications in 2018
Figure In-Patient
Figure Out-Patient
Figure Global Acute Respiratory Distress Syndrome Therapeutics Revenue (Million USD) (2014-2025)
Figure Global Acute Respiratory Distress Syndrome Therapeutics Production (K Pcs) (2014-2025)
Figure North America Acute Respiratory Distress Syndrome Therapeutics Market Size (Million USD) (2014-2025)
Figure Europe Acute Respiratory Distress Syndrome Therapeutics Market Size (Million USD) (2014-2025)
Figure China Acute Respiratory Distress Syndrome Therapeutics Market Size (Million USD) (2014-2025)
Figure Japan Acute Respiratory Distress Syndrome Therapeutics Market Size (Million USD) (2014-2025)
Figure Southeast Asia Acute Respiratory Distress Syndrome Therapeutics Market Size (Million USD) (2014-2025)
Figure India Acute Respiratory Distress Syndrome Therapeutics Market Size (Million USD) (2014-2025)
Table Acute Respiratory Distress Syndrome Therapeutics Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Acute Respiratory Distress Syndrome Therapeutics in 2018
Figure Manufacturing Process Analysis of Acute Respiratory Distress Syndrome Therapeutics
Figure Industry Chain Structure of Acute Respiratory Distress Syndrome Therapeutics
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Acute Respiratory Distress Syndrome Therapeutics Manufacturing Plants Distribution
Table Acute Respiratory Distress Syndrome Therapeutics Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Acute Respiratory Distress Syndrome Therapeutics Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Acute Respiratory Distress Syndrome Therapeutics Production (K Pcs) of Major Manufacturers (2014-2019)
Table Acute Respiratory Distress Syndrome Therapeutics Production Market Share of Major Manufacturers (2014-2019)
Figure Acute Respiratory Distress Syndrome Therapeutics Production Share by Manufacturers in 2018
Table Acute Respiratory Distress Syndrome Therapeutics Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share of Major Manufacturers (2014-2019)
Figure Acute Respiratory Distress Syndrome Therapeutics Revenue Share by Manufacturers in 2018
Table Acute Respiratory Distress Syndrome Therapeutics Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Acute Respiratory Distress Syndrome Therapeutics Production by Regions 2014-2019 (K Pcs)
Table Global Acute Respiratory Distress Syndrome Therapeutics Production Market Share by Regions 2014-2019
Figure Global Acute Respiratory Distress Syndrome Therapeutics Production Market Share by Regions in 2018
Table Global Acute Respiratory Distress Syndrome Therapeutics Revenue by Regions 2014-2019 (Million USD)
Table Global Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share by Regions 2014-2019
Figure Global Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share by Regions in 2018
Table Global Acute Respiratory Distress Syndrome Therapeutics Consumption by Regions 2014-2019 (K Pcs)
Table Global Acute Respiratory Distress Syndrome Therapeutics Consumption Market Share by Regions 2014-2019
Figure North America Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure North America Acute Respiratory Distress Syndrome Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table North America Acute Respiratory Distress Syndrome Therapeutics Production, Consumption Import and Export (K Pcs)
Figure Europe Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Acute Respiratory Distress Syndrome Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Acute Respiratory Distress Syndrome Therapeutics Production, Consumption Import and Export (K Pcs)
Figure China Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure China Acute Respiratory Distress Syndrome Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table China Acute Respiratory Distress Syndrome Therapeutics Production, Consumption Import and Export (K Pcs)
Figure Japan Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Acute Respiratory Distress Syndrome Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Acute Respiratory Distress Syndrome Therapeutics Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Acute Respiratory Distress Syndrome Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Acute Respiratory Distress Syndrome Therapeutics Production, Consumption Import and Export (K Pcs)
Figure India Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure India Acute Respiratory Distress Syndrome Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table India Acute Respiratory Distress Syndrome Therapeutics Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Acute Respiratory Distress Syndrome Therapeutics Market Share by Application (2014-2019)
Figure Global Value (Consumption) Acute Respiratory Distress Syndrome Therapeutics Market Share by Application (2014-2019)
Table Therabron Therapeutics, Inc. Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
Table Therabron Therapeutics, Inc. Acute Respiratory Distress Syndrome Therapeutics Product Introduction, Application and Specification
Table Therabron Therapeutics, Inc. Acute Respiratory Distress Syndrome Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Therabron Therapeutics, Inc. Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate (2014-2019)
Table Therabron Therapeutics, Inc. Acute Respiratory Distress Syndrome Therapeutics Production Market Share (2014-2019)
Figure Therabron Therapeutics, Inc. Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share (2014-2019)
Table Therabron Therapeutics, Inc. Acute Respiratory Distress Syndrome Therapeutics Main Business and Markets Served
Table Serendex Pharmaceuticals A/S Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
Table Serendex Pharmaceuticals A/S Acute Respiratory Distress Syndrome Therapeutics Product Introduction, Application and Specification
Table Serendex Pharmaceuticals A/S Acute Respiratory Distress Syndrome Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Serendex Pharmaceuticals A/S Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate (2014-2019)
Table Serendex Pharmaceuticals A/S Acute Respiratory Distress Syndrome Therapeutics Production Market Share (2014-2019)
Figure Serendex Pharmaceuticals A/S Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share (2014-2019)
Table Serendex Pharmaceuticals A/S Acute Respiratory Distress Syndrome Therapeutics Main Business and Markets Served
Table Silence Therapeutics Plc Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
Table Silence Therapeutics Plc Acute Respiratory Distress Syndrome Therapeutics Product Introduction, Application and Specification
Table Silence Therapeutics Plc Acute Respiratory Distress Syndrome Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Silence Therapeutics Plc Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate (2014-2019)
Table Silence Therapeutics Plc Acute Respiratory Distress Syndrome Therapeutics Production Market Share (2014-2019)
Figure Silence Therapeutics Plc Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share (2014-2019)
Table Silence Therapeutics Plc Acute Respiratory Distress Syndrome Therapeutics Main Business and Markets Served
Table Histocell S.L. Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
Table Histocell S.L. Acute Respiratory Distress Syndrome Therapeutics Product Introduction, Application and Specification
Table Histocell S.L. Acute Respiratory Distress Syndrome Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Histocell S.L. Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate (2014-2019)
Table Histocell S.L. Acute Respiratory Distress Syndrome Therapeutics Production Market Share (2014-2019)
Figure Histocell S.L. Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share (2014-2019)
Table Histocell S.L. Acute Respiratory Distress Syndrome Therapeutics Main Business and Markets Served
Table Altor BioScience Corporation Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
Table Altor BioScience Corporation Acute Respiratory Distress Syndrome Therapeutics Product Introduction, Application and Specification
Table Altor BioScience Corporation Acute Respiratory Distress Syndrome Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Altor BioScience Corporation Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate (2014-2019)
Table Altor BioScience Corporation Acute Respiratory Distress Syndrome Therapeutics Production Market Share (2014-2019)
Figure Altor BioScience Corporation Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share (2014-2019)
Table Altor BioScience Corporation Acute Respiratory Distress Syndrome Therapeutics Main Business and Markets Served
Table Athersys, Inc. Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
Table Athersys, Inc. Acute Respiratory Distress Syndrome Therapeutics Product Introduction, Application and Specification
Table Athersys, Inc. Acute Respiratory Distress Syndrome Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Athersys, Inc. Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate (2014-2019)
Table Athersys, Inc. Acute Respiratory Distress Syndrome Therapeutics Production Market Share (2014-2019)
Figure Athersys, Inc. Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share (2014-2019)
Table Athersys, Inc. Acute Respiratory Distress Syndrome Therapeutics Main Business and Markets Served
Table Faron Pharmaceuticals Oy Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
Table Faron Pharmaceuticals Oy Acute Respiratory Distress Syndrome Therapeutics Product Introduction, Application and Specification
Table Faron Pharmaceuticals Oy Acute Respiratory Distress Syndrome Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Faron Pharmaceuticals Oy Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate (2014-2019)
Table Faron Pharmaceuticals Oy Acute Respiratory Distress Syndrome Therapeutics Production Market Share (2014-2019)
Figure Faron Pharmaceuticals Oy Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share (2014-2019)
Table Faron Pharmaceuticals Oy Acute Respiratory Distress Syndrome Therapeutics Main Business and Markets Served
Table FirstString Research, Inc. Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
Table FirstString Research, Inc. Acute Respiratory Distress Syndrome Therapeutics Product Introduction, Application and Specification
Table FirstString Research, Inc. Acute Respiratory Distress Syndrome Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table FirstString Research, Inc. Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate (2014-2019)
Table FirstString Research, Inc. Acute Respiratory Distress Syndrome Therapeutics Production Market Share (2014-2019)
Figure FirstString Research, Inc. Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share (2014-2019)
Table FirstString Research, Inc. Acute Respiratory Distress Syndrome Therapeutics Main Business and Markets Served
Table GlaxoSmithKline Plc Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
Table GlaxoSmithKline Plc Acute Respiratory Distress Syndrome Therapeutics Product Introduction, Application and Specification
Table GlaxoSmithKline Plc Acute Respiratory Distress Syndrome Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table GlaxoSmithKline Plc Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate (2014-2019)
Table GlaxoSmithKline Plc Acute Respiratory Distress Syndrome Therapeutics Production Market Share (2014-2019)
Figure GlaxoSmithKline Plc Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share (2014-2019)
Table GlaxoSmithKline Plc Acute Respiratory Distress Syndrome Therapeutics Main Business and Markets Served
Table Phylogica Limited Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
Table Phylogica Limited Acute Respiratory Distress Syndrome Therapeutics Product Introduction, Application and Specification
Table Phylogica Limited Acute Respiratory Distress Syndrome Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Phylogica Limited Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate (2014-2019)
Table Phylogica Limited Acute Respiratory Distress Syndrome Therapeutics Production Market Share (2014-2019)
Figure Phylogica Limited Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share (2014-2019)
Table Phylogica Limited Acute Respiratory Distress Syndrome Therapeutics Main Business and Markets Served
Figure Global Acute Respiratory Distress Syndrome Therapeutics Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Acute Respiratory Distress Syndrome Therapeutics Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Acute Respiratory Distress Syndrome Therapeutics Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Acute Respiratory Distress Syndrome Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Acute Respiratory Distress Syndrome Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Acute Respiratory Distress Syndrome Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Acute Respiratory Distress Syndrome Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Acute Respiratory Distress Syndrome Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Acute Respiratory Distress Syndrome Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Acute Respiratory Distress Syndrome Therapeutics by Type (2019-2025)
Table Global Consumption (K Pcs) of Acute Respiratory Distress Syndrome Therapeutics by Application (2019-2025)
Table Acute Respiratory Distress Syndrome Therapeutics Distributors List
Table Acute Respiratory Distress Syndrome Therapeutics Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

【掲載企業】

Therabron Therapeutics, Inc.、Serendex Pharmaceuticals A/S、Silence Therapeutics Plc、Histocell S.L.、Altor BioScience Corporation、Athersys, Inc.、Faron Pharmaceuticals Oy、FirstString Research, Inc.、GlaxoSmithKline Plc、Phylogica Limited、

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の急性呼吸窮迫症候群(ARDS)治療薬市場(Global Acute Respiratory Distress Syndrome Therapeutics Market Professional Survey Report 2019)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp